These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates. Florell SR, Cessna M, Lundell RB, Boucher KM, Bowen GM, Harris RM, Petersen MJ, Zone JJ, Tripp S, Perkins SL. Am J Clin Pathol; 2006 May; 125(5):727-36. PubMed ID: 16707374 [Abstract] [Full Text] [Related]
36. Mycosis fungoides associated with unusual epidermal hyperplasia. Puig L, Musulén E, Fernández-Figueras MT, Miralles J, Sitjas D, De Moragas JM. Clin Exp Dermatol; 1996 Jan; 21(1):61-4. PubMed ID: 8689775 [Abstract] [Full Text] [Related]
37. Pediatric CD8⁺CD56⁺ non-poikilodermatous mycosis fungoides: case report and review of the literature. Kempf W, Kazakov DV, Broekaert SM, Metze D. Am J Dermatopathol; 2014 Jul; 36(7):598-602. PubMed ID: 24698938 [Abstract] [Full Text] [Related]
38. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm). Su O, Onsun N, Demirkesen C, Aydin Y, Pirmit S, Gereli M. Dermatol Online J; 2010 Apr 15; 16(4):8. PubMed ID: 20409415 [Abstract] [Full Text] [Related]
40. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study. Apisarnthanarax N, Talpur R, Ward S, Ni X, Kim HW, Duvic M. J Am Acad Dermatol; 2004 Apr 15; 50(4):600-7. PubMed ID: 15034511 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]